AccurKardia Discovered First-of-its-kind Aortic Valve Stenosis ECG-based AI Screening Software
AccurKardia has introduced a groundbreaking ECG-based AI screening software for detecting aortic valve stenosis (AVS).
This first-of-its-kind solution leverages the widespread use of electrocardiograms (ECGs) to scan millions of existing ECG records within healthcare systems, helping to identify patients who may require echocardiograms for a definitive AVS diagnosis.
Designed to address challenges in early detection, this innovative AI technology complements the readily accessible ECG, enabling earlier identification of at-risk patients more efficiently.
The software is especially valuable in underserved areas where access to cardiology specialists and advanced imaging is limited.
Aortic valve stenosis, a life-threatening heart condition common in elderly individuals, is typically diagnosed through bedside examination and echocardiography. However, many cases are overlooked due to factors like poor symptom recognition in elderly patients, absence of murmurs, time constraints during primary care visits, and limited access to diagnostic imaging.
By facilitating earlier detection and intervention, this new AVS screening software has the potential to significantly reduce healthcare costs for payers, optimise resource allocation, and promote the long-term sustainability of healthcare systems.